Matthew Harms is currently the Senior Manager of Search and Evaluation at Amgen, a position they began in 2024. Previously, Harms served as a Senior Scientist II and Project Team Lead in Discovery Biology at Scribe Therapeutics from 2021 to 2024, and as an Associate Principal Scientist at AstraZeneca in 2020 and 2021. They earned a PhD in Cell/Cellular and Molecular Biology from the University of Pennsylvania School of Medicine, where they were a candidate from 2009 to 2014, after completing a BS in Physiology at the University of California, Santa Barbara in 2008. Harms’ early career includes roles as a Laboratory Technician and Undergraduate Researcher, providing a solid foundation for their extensive experience in scientific research and development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices